ArticlePolymers2026
Hyaluronic Acid Molecular Weight Modulates Chitosan-Gelatin Scaffold Properties and Cancer Cell Organization in 3D Culture.
Article in Polymers, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Reconstructing physiologically relevant in vitro tumor microenvironments (TMEs) that capture coupled biophysical and biochemical complexities remains a significant challenge in cancer modeling. Here, we present a tunable chitosan-gelatin-hyaluronic acid (HA) scaffold platform stabilized by Schiff-base (C=N) crosslinking to investigate how HA molecular weight (MW) affects scaffold architecture, hydration behavior, mechanical properties, degradation stability, and cancer cell organization. We established an isocompositional series of HA-containing scaffolds, with HA MW as the primary variable and polymer composition held constant across all HA-containing groups. Varying HA MW modulated pore morphology, swelling behavior, compressive modulus, and degradation profiles, demonstrating distinct effects on scaffold structural organization. Medium-MW HA yielded a balanced scaffold architecture characterized by high porosity, controlled swelling behavior, and stable mechanical performance under hydrated conditions. A549 cells exhibited a compact, spheroid-like organization, whereas PANC-1 cells displayed more protrusive, spread morphologies that varied with scaffold formulation. Conversely, HA-free scaffolds showed reduced structural stability and less organized three-dimensional (3D) cell morphology. Collectively, these findings substantiate that HA MW is an effective design parameter for tuning scaffold physicochemical properties and influencing scaffold-associated cancer cell organization in 3D culture. This study provides a tunable scaffold platform for future in vitro tumor microenvironment modeling.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.